- Home
- TVGN vs FORA Comparison
TVGN vs FORA Comparison
Compare TVGN & FORA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
N/A
Current Price
$2.06
Company Overview
Basic Information| Metric | TVGN | FORA |
|---|---|---|
| Founded | 2020 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Blank Checks | Computer Software: Prepackaged Software |
| Sector | Finance | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 63.9M | 66.2M |
| IPO Year | N/A | 2020 |
Fundamental Metrics
Financial Performance| Metric | TVGN | FORA |
|---|---|---|
| Price | $4.27 | $2.06 |
| Analyst Decision | Hold | |
| Analyst Count | 1 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 363.6K | 13.9K |
| Earning Date | 05-13-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $20,153,263.00 |
| Revenue This Year | N/A | $51.82 |
| Revenue Next Year | N/A | $7.24 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.14 | $1.64 |
| 52 Week High | $10.76 | $2.71 |
Technical Indicators
Market Signals| Indicator | TVGN | FORA |
|---|---|---|
| Relative Strength Index (RSI) | 53.47 | 48.03 |
| Support Level | $0.53 | $2.04 |
| Resistance Level | $10.76 | $2.12 |
| Average True Range (ATR) | 0.75 | 0.02 |
| MACD | -0.26 | 0.00 |
| Stochastic Oscillator | 3.04 | 55.56 |
Price Performance
Historical Comparison TVGN
FORA
About TVGN Tevogen Bio Holdings Inc.
Tevogen Bio Holdings Inc a clinical-stage specialty immunotherapy company harnessing CD8+ cytotoxic T lymphocytes (CD8+ CTLs or CTLs), to develop off-the-shelf, precision T cell therapies for the treatment of infectious diseases, cancers, and neurological disorders.
About FORA Forian Inc.
Forian Inc provides a suite of Software, data management capabilities, and proprietary data and analytics to optimize and measure operational, clinical, and financial performance for customers within the traditional and emerging life sciences, healthcare payer, and provider segments, as well as cannabis dispensaries, manufacturers, and cultivators.